NG
TEVA icon

Northstar Group’s Teva Pharmaceuticals TEVA Stock Holding History

Northstar Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,568
Closed -$140K – 130
2020
Q1 		$140K Hold
15,568
– – 0.06% 123
2019
Q4 		$153K Hold
15,568
– – 0.06% 130
2019
Q3 		$107K Sell
15,568
-5,000
-24% -$38.3K 0.04% 130
2019
Q2 		$190K Buy
20,568
+1,600
+8% +$19.3K 0.08% 133
2019
Q1 		$297K Buy
18,968
+3,500
+23% +$61.7K 0.13% 112
2018
Q4 		$239K Buy
15,468
+4,000
+35% +$82K 0.12% 114
2018
Q3 		$247K Hold
11,468
– – 0.11% 119
2018
Q2 		$279K Hold
11,468
– – 0.14% 112
2018
Q1 		$196K Sell
11,468
-7,000
-38% -$137K 0.1% 119
2017
Q4 		$276K Sell
18,468
-5,500
-23% -$82.7K 0.15% 101
2017
Q3 		$422K Sell
23,968
-80
-0.3% -$1.8K 0.24% 86
2017
Q2 		$799K Buy
24,048
+2,500
+12% +$77.4K 0.49% 58
2017
Q1 		$694K Buy
21,548
+8,750
+68% +$299K 0.46% 58
2016
Q4 		$464K Buy
+12,798
New +$511K 0.32% 70

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northstar Group's TEVA Position: Q2 2020 in Review

Northstar Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 15,568 shares — an estimated $140K sold.

Northstar Group first reported a position in TEVA in Q4 2016 and held it in 14 quarters. The position peaked at $799K in Q2 2017. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Northstar Group reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Northstar Group sold 15,568 Teva Pharmaceuticals shares in Q2 2020, an estimated $140K.
  • Northstar Group first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 14 quarters.
  • Northstar Group's Teva Pharmaceuticals position peaked at $799K in Q2 2017.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Northstar Group's 13F filing for Q2 2020, filed 11 Aug 2020.